Provinces are preparing to roll out the Pfizer-BioNTech COVID-19 vaccine after it was approved by Health Canada on Wednesday, with many hoping to start inoculating high-risk populations like health-care workers and long-term care residents by next week.
Prime Minister Justin Trudeau said Thursday “the first 30,000 doses are expected to arrive in just a few days” and that the vaccine will be “free for Canadians” with the federal government covering the costs. But the logistics of storing the Pfizer-BioNTech vaccine has presented provinces with challenges, and all but rule out the territories from receiving them.
Here is a look at plans across the country.
Alberta
About 3,900 doses of the Pfizer-BioNTech vaccine will arrive in Alberta next week, and immunizations for ICU doctors and nurses, respiratory therapists and long-term care workers are expected to begin Dec. 16. Since two doses are required, that means around 1,950 people will be immunized.
Because the initial doses of the vaccine can be administered only at the sites where it is delivered — due to the need for ultra-cold storage — the province is not yet able to begin vaccinating patients at facilities. Instead, shots will be given at the two initial shipment locations in Edmonton and Calgary.
WATCH | Pfizer-BioNTech vaccine makes dry ice a hot commodity:
[embedded content]
The first acute-care staff to get the vaccines will come from the Foothills Hospital and the Peter Lougheed Centre in Calgary, and from University of Alberta and Royal Alexandra hospitals in Edmonton. Alberta Health Services will book appointments for those staff to receive their second dose when they receive their first.
The Government of Alberta says it anticipates it will be able to immunize up to 435,000 Albertans who are most at-risk between January and March 2021.
Starting in January, the following groups will receive the vaccine:
Long-term care and some supported living residents and staff.
Seniors age 75 and older.
On-reserve First Nations people over age 65.
Health-care workers most needed to ensure workforce capacity.
Ontario
Ontario will administer its first COVID-19 vaccines next Tuesday at two hospitals in Toronto and Ottawa.
The first vaccines will go to health-care workers at long-term care homes and other high-risk places, Premier Doug Ford said in a news release.
More details are set to be provided on Friday, Ford’s statement said.
Manitoba
Manitoba is slated to receive doses next week, and expects to receive enough to vaccinate more than 100,000 people by March 31 of next year.
The first 1,950 doses are reserved for health-care workers in the critical care field, the vast majority of whom work in Winnipeg. Over the next three months, more locations will be established in Winnipeg, Brandon, Thompson, Steinbach, Gimli, Portage la Prairie and The Pas.
Details on how the first 900 health workers can book appointments to get the vaccine will be released in the coming days.
Beyond that, the province is still working out details on how it will notify people that they are eligible for the vaccine.
WATCH | Health-care workers to receive first Manitoba COVID-19 vaccines:
Health-care workers in critical-care units will be the first in Manitoba to get the COVID-19 vaccine once initial doses — enough for about 900 people — arrive in the province next week, Premier Brian Pallister says. 1:54
Saskatchewan
Vaccine doses will start arriving in Saskatchewan next week and will be given to health-care workers at Regina General Hospital who provide direct care to COVID-19 patients.
Phase 1 of the province’s vaccine delivery plan — with 202,052 doses expected within the first quarter of 2021 — will focus on health-care workers, elderly residents in care homes, seniors over 80 and residents in northern remote communities.
Phase 2 of the vaccine rollout, which will see the general population begin to be vaccinated, is scheduled to begin in April 2021.
British Columbia
B.C. plans on immunizing 400,000 people against COVID-19 by March 2021, with priority given to residents and staff of long-term care homes and health-care workers.
As more doses of the vaccine become available, priority will be given to seniors over 80, people with underlying health conditions, people who are underhoused, and people living in remote and isolated Indigenous communities.
By April, front-line workers including teachers, grocery store workers, firefighters and people working in food processing plants will be prioritized.
As doses increase, Provincial Health Officer Dr. Bonnie Henry says vaccines will be distributed, moving down the population age range in increments.
WATCH | Approved COVID-19 vaccine brings hope to anxious Canadians:
The approval of the Pfizer-BioNTech COVID-19 vaccine will be life-changing for many vulnerable Canadians who have been anxiously awaiting the rollout. 2:02
Quebec
A limited number of vaccine doses will likely be available in Quebec starting next week.
Patients in residential and long-term care centres, which accounted for the vast majority of deaths related to COVID-19, will be the first to get the Pfizer-BioNTech vaccine in the province as early as next Monday. Patients will receive the vaccinations on site.
People living in private seniors’ residences and those in isolated communities, including Indigenous communities and particularly those located in Nunavik and James Bay, will be next.
The next groups to receive the vaccine will be organized by age, starting with those 80 and up, then 70 to 79, and 60 to 69, followed by those who are 60 and under and have other risk factors.
New Brunswick
The first doses of Pfizer-BioNTech’s vaccine will arrive in New Brunswick around Dec. 14, with a second shipment before the end of the year.
The first shipment will be delivered to the Miramichi Regional Hospital, said Greg MacCallum, director of the New Brunswick Emergency Measures Organization, who is leading the rollout of the vaccine. It was chosen based on its central location, said MacCallum. The hospital — which has installed an ultra-low-temperature freezer — can be reached within two or three hours from virtually anywhere in the province, he said.
Health Minister Dorothy Shephard said long-term care residents and staff, health-care workers, emergency responders and seniors will be prioritized.
WATCH | New Brunswick outlines vaccination plan:
Greg MacCallum announced vaccine rollout plan and said the first shipment will be sent to Miramichi 4:48
Newfoundland and Labrador
Health Minister John Haggie said a thermal shipper — used to keep vaccine doses at a consistent temperature during transport — arrived in N.L. on Wednesday, with vaccine deliveries expected next week.
Haggie said the province’s vaccine committee also met on Wednesday morning with distribution plans “significantly advanced.” He said by the time the vaccine arrives the province will be in a position to “highlight” high-risk groups who will receive the first doses.
Prince Edward Island
Chief Public Health Officer Dr. Heather Morrison said the first doses of COVID-19 vaccine could arrive on P.E.I. as early as next week, allowing the province to vaccinate 1,000 people, starting with the most vulnerable: residents and staff in long-term care.
Nova Scotia is expecting one batch of 1,950 doses of the Pfizer-BioNTech vaccine this month, with regular weekly allotments starting in January.
The first people in the province to receive the vaccine will be front-line health-care workers, Chief Medical Officer of Health Dr. Robert Strang announced Tuesday.
Premier Stephen McNeil said Nova Scotia chose to target frontline health-care workers first because they are the ones most likely to transmit the virus to long-term care residents and the elderly.
Right now the only freezer in the province with temperatures cold enough to store the vaccines is in Halifax. As such, the first doses will have to be administered in the central zone.
McNeil said anyone tapped for priority access who is outside the Halifax area will be brought in to receive their dose.
Territories
That first batch of nearly 250,000 doses of Pfizer-BioNTech’s vaccine will be available in Canada before the end of the year, but none will go to the territories. The North lacks the freezers needed to store the Pfizer-BioNTech vaccine, which the company says requires a freezer at -80 C to -60 C or a thermal container at -90 C to -60 C.
Dr. Michael Patterson, Nunavut’s chief public health officer, said the territory is more likely to get the Moderna vaccine because the Pfizer-BioNTech vaccine’s strict storage and shipping requirements aren’t appropriate for remote communities. He said Nunavut’s vaccines would be mostly, if not entirely, from Moderna.
Similarly, Yukon officials announced that the Moderna vaccine will begin arriving in the territory in January. Premier Sandy Silver said Thursday that all adults who want the vaccine will receive it for free, within the first three months of 2021.
Health Minister Pauline Frost said Yukon will get 50,400 doses by the end of March. This is enough to cover 25,000 people according to a government statement. Frost said priority will be given to residents and staff of long-term care homes, health-care and personal support workers, adults over 80, and Yukon residents in rural or remote communities.
The Northwest Territories government expects the Moderna vaccine to be available to 75 per cent of the territory’s “eligible population” in “early 2021,” according to a statement issued Thursday.
NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.
The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.
Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.
“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”
More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.
Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.
The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.
However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.
Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.
“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.
What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.
In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.
Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.
Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.
Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.
However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.
Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.
Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)
There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.
“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.
That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.
Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.
“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.
Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.
When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.
The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.
The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.
Worldwide, around 585 volcanoes are considered active.
Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.
Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.
(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.
The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.
After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.
Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.
Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.
“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.
Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.
But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.
Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.
Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.
Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.
That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.
Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.
Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.